story of the week
Safety, Tolerability, and Efficacy of Idarucizumab for the Reversal of the Anticoagulant Effect of Dabigatran in Healthy Men
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety, Tolerability, and Efficacy of Idarucizumab for the Reversal of the Anticoagulant Effect of Dabigatran in Healthy Male Volunteers: a Randomised, Placebo-Controlled, Double-Blind Phase 1 Trial
Lancet 2015 Jun 15;[EPub Ahead of Print], S Glund, J Stangier, M Schmohl, D Gansser, S Norris, J van Ryn, B Lang, S Ramael, V Moschetti, F Gruenenfelder, P Reilly, J KreuzerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.